Days Alive and Out of the Hospital After Heart Transplantation: A Retrospective Cohort Study

Marcus R Bruce1, Peter E Frasco2, Kristen A Sell-Dottin3

  • 1Department of Anesthesiology and Perioperative Medicine, Cardiothoracic Division, University of California San Diego, San Diego, CA.

Insights

Mechanical circulatory support (MCS) as a bridge to heart transplant did not significantly impact days alive and out of the hospital (DAOH) at 365 days. This outcome measure is crucial for understanding the post-transplant patient experience.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Outcomes Research

Background:

  • Orthotopic heart transplantation is a life-saving procedure for end-stage heart failure.
  • Mechanical circulatory support (MCS) is increasingly used as a bridge to transplant.
  • Evaluating post-transplant outcomes is essential for optimizing patient care.

Purpose of the Study:

  • To assess if mechanical circulatory support (MCS) as a bridge to heart transplant affects the primary outcome of days alive and out of the hospital (DAOH) at 365 days post-transplant.
  • To compare DAOH365 in patients with and without prior MCS.
  • To identify predictors of reduced DAOH365.

Main Methods:

  • Retrospective observational study of 235 adult heart transplant recipients between 2015 and 2020.
  • Primary outcome: DAOH at 365 days (DAOH365).
  • Poisson regression analysis was used to determine associations between variables and DAOH365.

Main Results:

  • The median DAOH365 for the entire cohort was 348 days.
  • No significant difference in DAOH365 was observed between patients with prior MCS (347 days) and those without MCS (348 days) (p=0.43).
  • Multivariate analysis identified the 2018 heart transplant allocation change, pretransplant pulmonary hypertension, and increased total ischemic time as predictors of reduced DAOH365.

Conclusions:

  • Prior use of MCS as a bridge to heart transplant did not significantly alter DAOH365.
  • DAOH is a valuable metric for understanding the post-transplant patient experience.
  • Incorporating DAOH into pre-transplant evaluations can enhance shared decision-making between patients and clinicians.
Abstract